Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

Drossman, 1997, Irritable bowel syndrome: a technical review for practice guideline development, Gastroenterology, 112, 2120, 10.1053/gast.1997.v112.agast972120 Manning, 1978, Towards positive diagnosis of the irritable bowel, Br Med J, 6138, 653, 10.1136/bmj.2.6138.653 Drossman, 1982, Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction, Gastroenterology, 83, 529, 10.1016/S0016-5085(82)80186-8 Kruis, 1984, A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease, Gastroenterology, 87, 1, 10.1016/0016-5085(84)90119-7 Whitehead, 1988, Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples, Gastroenterology, 95, 709, 10.1016/S0016-5085(88)80018-0 Talley, 1989, A patient questionnaire to identify bowel disease, Ann Intern Med, 111, 671, 10.7326/0003-4819-111-8-671 Talley, 1990, Diagnostic value of the Manning criteria in irritable bowel syndrome, Gut, 31, 77, 10.1136/gut.31.1.77 Smith, 1991, Gender differences in Manning criteria in the irritable bowel syndrome, Gastroenterology, 100, 591, 10.1016/0016-5085(91)80002-Q Thompson, 1994, Functional bowel disorders and functional abdominal pain, 115 1994, 339 Harris, 1997, Irritable bowel syndrome. A cost-effective approach for primary care physicians, Postgrad Med, 101, 215, 10.3810/pgm.1997.03.184 Camilleri, 1992, The irritable bowel syndrome: mechanisms and a practical approach to management, Ann Intern Med, 116, 1001, 10.7326/0003-4819-116-12-1001 Drossman, 1992, The irritable bowel syndrome: review and a graduated multicomponent treatment approach, Ann Intern Med, 116, 1009, 10.7326/0003-4819-116-12-1009 Tolliver, 1994, Evaluation of patients who meet clinical criteria for irritable bowel syndrome, Am J Gastroenterol, 89, 176 Dale, 1985, Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin, Am J Clin Pathol, 84, 24, 10.1093/ajcp/84.1.24 Fagerhol, 1990, Calprotectin (the L1 leukocyte protein), 187 Roseth, 1997, Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein, Digestion, 58, 176, 10.1159/000201441 Roseth, 1992, Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study, Scand J Gastroenterol, 27, 793, 10.3109/00365529209011186 Kristinsson, 1998, Fecal calprotectin concentration in patients with colorectal carcinoma, Dis Colon Rectum, 41, 316, 10.1007/BF02237485 Meling, 1996, Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs, Scand J Gastroenterol, 31, 339, 10.3109/00365529609006407 Teahon, 1997, Faecal calprotectin: a simple sensitive quantitative measure of intestinal inflammation in man (abstr), Gastroenterology, 112, A1103 Tibble, 2001, Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma, Gut, 49, 402, 10.1136/gut.49.3.402 Tibble, 1999, High prevalence of NSAID enteropathy as demonstrated by a simple faecal test, Gut, 45, 362, 10.1136/gut.45.3.362 Bjarnason, 1995, Intestinal permeability: an overview, Gastroenterology, 108, 1566, 10.1016/0016-5085(95)90708-4 Drossman, 1999, The functional gastrointestinal disorders and the Rome II process, Gut, 45, 1 Sigthorsson, 1998, Intestinal permeability and inflammation in patients on NSAID's, Gut, 43, 506, 10.1136/gut.43.4.506 Teahon, 1992, Intestinal permeability in patients with Crohn's disease and their first degree relatives, Gut, 33, 320, 10.1136/gut.33.3.320 Henderson, 1993, Assessing test accuracy on its clinical consequence: a primer for receiver operating characteristics curve analysis, Ann Clin Biochem, 30, 521, 10.1177/000456329303000601 Royston, 1991, Estimating departure from normality, Stat Med, 10, 1283, 10.1002/sim.4780100811 Cox, 1972, Regression models and life tables, J Royal Stat Soc, B34, 187 Morris, 1991, Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs, Lancet, 337, 520, 10.1016/0140-6736(91)91300-J Drossman, 1988, Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome, Gastroenterology, 95, 701, 10.1016/S0016-5085(88)80017-9 Thompson, 1980, Functional bowel disorders in apparently healthy people, Gastroenterology, 79, 283, 10.1016/0016-5085(80)90142-0 Bommelaer, 1986, Epidemiology of intestinal functional disorders in an apparently healthy population, Gastroenterol Clin Biol, 10, 7 Mitchell, 1987, Survey of the AGA membership relating to patients with functional gastrointestinal disorders, Gastroenterology, 92, 1282, 10.1016/S0016-5085(87)91099-7 Thompson, 2000, Irritable bowel syndrome in general practice: prevalence, characteristics and referral, Gut, 46, 78, 10.1136/gut.46.1.78 Thompson, 1993, Irritable bowel syndrome: pathogenesis and management, Lancet, 341, 1569, 10.1016/0140-6736(93)90705-L Bennett, 1998, Level of chronic life stress predicts clinical outcome in irritable bowel syndrome, Gut, 43, 256, 10.1136/gut.43.2.256 Shaw, 1998, Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population, Aliment Pharmacol Ther, 12, 1067, 10.1046/j.1365-2036.1998.00399.x Kay, 1998, Irritable bowel syndrome: which definitions are consistent?, J Intern Med, 244, 489, 10.1111/j.1365-2796.1998.00393.x Bensoussan, 1998, Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial, JAMA, 280, 1585, 10.1001/jama.280.18.1585 Patrick, 1998, Quality of life in persons with irritable bowel syndrome: development and validation of a new measure, Dig Dis Sci, 43, 400, 10.1023/A:1018831127942 Tibble, 2000, A simple method for assessing intestinal inflammation in Crohn's disease, Gut, 47, 506, 10.1136/gut.47.4.506 Tibble, 2000, Surrogate markers of intestinal inflammation are predictive of relapse in patients with quiescent inflammatory bowel disease, Gastroenterology, 119, 15, 10.1053/gast.2000.8523 Gilbert, 1996, Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin, Scand J Gastroenterol, 31, 1001, 10.3109/00365529609003120 Allison, 1992, Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs, N Engl J Med, 327, 749, 10.1056/NEJM199209103271101 Morris, 1992, Small bowel enteroscopy in undiagnosed gastrointestinal blood loss, Gut, 33, 887, 10.1136/gut.33.7.887 Somasundaram, 1995, The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis, Scand J Gastroenterol, 30, 289, 10.3109/00365529509093280